Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 101
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Rev Neurol (Paris) ; 168(12): 887-900, 2012 Dec.
Artigo em Francês | MEDLINE | ID: mdl-23153685

RESUMO

We report 124 cases of somatoform disorders, considering psychogenic disorders at the same level as neurological disorders. We noted any psychic, somatic or social condition (history taking) and facilitating circumstances. The patients were aged 16 to 84 years old; 71.7% were women. We observed pain (35.4%), psychogenic headache (25%), sensorimotor loss (27.4%), gait and psychogenic tremor (17.7%), cognitive disorders (11.8%), ocular symptoms (7.2%), and urogenital symptoms (2.4%). Delay to consultation ranged from a few days to 20 years. Psychiatric comorbidity was noted in 30.6% of the cases. In 55.6% of 124 cases, we observed a psychological background. It was a childhood trauma in 15.3% of these cases. In one-third of the 124 situations, we noted an underlying somatic or social condition. Facilitation conditions were frequently mixed. Somatic and/or psychological conditions were noted in one-third of the 124 cases and social conditions in half of them. The neurologist is faced with the challenge of naming the symptom (most often labelled a functional disorder) and of making the decision to stop or limit investigations. Visits by patients with psychogenic disorders make up a significant percentage of neurology speciality appointments. The neurologist should not limit the consultation to differentiating "real" symptoms from psychogenic somatoform disorders, but should also propose a straightforward compassionate approach for effective therapeutic care. By carefully listening to the patient's dialogue, the neurologist can help the patient give meaning to the symptoms, and progress towards improved well-being.


Assuntos
Doenças do Sistema Nervoso/terapia , Transtornos Somatoformes/terapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Transtorno Conversivo/diagnóstico , Transtorno Conversivo/terapia , Família , Conflito Familiar , Medo , Feminino , Humanos , Masculino , Doença de Meniere/induzido quimicamente , Doença de Meniere/terapia , Pessoa de Meia-Idade , Transtornos de Enxaqueca/complicações , Doenças do Sistema Nervoso/diagnóstico , Exame Neurológico , Testes Neuropsicológicos , Transtorno de Pânico/psicologia , Transtorno de Pânico/terapia , Gravidez , Gravidez Ectópica/psicologia , Gravidez Ectópica/terapia , Meio Social , Transtornos Somatoformes/diagnóstico , Adulto Jovem
2.
Rev Neurol (Paris) ; 167(4): 343-7, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21429544

RESUMO

INTRODUCTION: Waldenström's disease (WD) is frequently associated with a predominantly sensory neuropathy with a progressive course due to the monoclonal IgM activity against Myelin Associated Glycoprotein (MAG). However, neurolymphomatosis or chronic demyelinating inflammatory polyneuropathy (CDIP) may occur in some patients with WD. CASE REPORT: We report a case of Waldenström's macroglobulinemia in an adult male presenting with cranial nerve palsy and rapidly progressive asymmetric polyneuropathy. Intravenous IgM treatment that provided transient amelioration was followed by a relapse involving tetraparesis. Cerebrospinal fluid analysis, medullar magnetic resonance imaging, and electrophysiological studies led to equivocal findings suggesting the presence of either neurolymphomatosis or CIDP. Finally, sural nerve biopsy results supported the diagnosis of CIDP, which then received appropriate treatment. CONCLUSION: In patients with WD, the possible occurrence of CIDP should be investigated with a neuromuscular biopsy when other investigations are equivocal since the disease calls for a specific treatment.


Assuntos
Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/etiologia , Macroglobulinemia de Waldenstrom/complicações , Doenças do Nervo Abducente/patologia , Corticosteroides/uso terapêutico , Adulto , Biópsia , Doenças dos Nervos Cranianos/etiologia , Doenças dos Nervos Cranianos/patologia , Ciclofosfamida/uso terapêutico , Diagnóstico Diferencial , Eletromiografia , Fenômenos Eletrofisiológicos , Humanos , Imunossupressores/uso terapêutico , Imageamento por Ressonância Magnética , Masculino , Microscopia Eletrônica , Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/diagnóstico , Nervo Sural/patologia , Nervo Sural/ultraestrutura , Macroglobulinemia de Waldenstrom/diagnóstico
3.
Rev Neurol (Paris) ; 166(12): 959-65, 2010 Dec.
Artigo em Francês | MEDLINE | ID: mdl-21056443

RESUMO

INTRODUCTION: Hereditary optic neuropathies, resulting from retinal ganglion cell degeneration, are a heterogeneous group of diseases ranging from asymptomatic forms to legal blindness. STATE OF KNOWLEDGE: Two most frequent phenotypes are Kjer's disease, an autosomal dominant optic atrophy caused by OPA1 gene mutations, and Leber's disease due to maternally inherited mitochondrial DNA mutations. PROSPECTS AND CONCLUSION: Both optic neuropathies usually isolated are sometimes associated with extraocular symptoms, especially neurological symptoms, thus justifying a systematic neurological evaluation and brain imaging.


Assuntos
Atrofias Ópticas Hereditárias/genética , Atrofias Ópticas Hereditárias/patologia , DNA Mitocondrial/genética , GTP Fosfo-Hidrolases/genética , Humanos , Mutação , Atrofias Ópticas Hereditárias/diagnóstico , Atrofia Óptica Autossômica Dominante/genética , Atrofia Óptica Autossômica Dominante/patologia , Atrofia Óptica Hereditária de Leber/genética , Atrofia Óptica Hereditária de Leber/patologia , Células Ganglionares da Retina/patologia
4.
Clin Neurol Neurosurg ; 110(7): 743-6, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18514392

RESUMO

Intraventricular meningiomas are infrequent intracranial tumors. Clinical symptoms are mainly due to an increased intracranial pressure or a direct pressure on the surrounding brain structures. Inflammatory syndrome was described in some patients with chordoid meningiomas. Here we report a case of right intraventricular clear cell meningioma in a 50-year-old man who presented with fever, headache, and inflammatory syndrome. Clinical and biological normalization was rapidly obtained after tumor removal. Immunohistochemical examination showed tumor cells and lymphocytes positivity for the pyrogenic cytokine interleukin-6, with a same intensity. To our knowledge, this is the first case described in the literature concerning an adult man with an intraventricular clear cell meningioma associated with a systemic inflammatory syndrome.


Assuntos
Inflamação/patologia , Neoplasias Meníngeas/diagnóstico , Meningioma/diagnóstico , Febre/etiologia , Humanos , Imuno-Histoquímica , Inflamação/etiologia , Interleucina-6/biossíntese , Ventrículos Laterais/metabolismo , Ventrículos Laterais/patologia , Imageamento por Ressonância Magnética , Masculino , Neoplasias Meníngeas/complicações , Neoplasias Meníngeas/cirurgia , Meningioma/complicações , Meningioma/cirurgia , Pessoa de Meia-Idade , Síndrome
5.
Clin Neurol Neurosurg ; 110(5): 514-7, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18342435

RESUMO

We report a case of a 9-month pregnant woman who presented acute psychiatric and neurological symptoms with extensive involvement of the white matter on MRI and no oligoclonal bands on CSF examination. Despite high doses of intravenous steroids, plasmapheresis and immunosuppressive drugs, a fatal outcome (coma) was noted 8 months later. Neuropathological examination confirmed the diagnosis of Marburg's type of multiple sclerosis showing sharp-edged lesions of demyelination, giant astrocytes, numerous macrophages and little perivascular inflammation. We discuss the definition and limits of the Marburg entity with reference to acute disseminated encephalomyelitis, impact of pregnancy, unusual MRI features, neuropathology and treatment.


Assuntos
Encéfalo/patologia , Encefalomielite Aguda Disseminada/patologia , Esclerose Múltipla/patologia , Complicações na Gravidez/patologia , Doença Aguda , Adulto , Diagnóstico Diferencial , Evolução Fatal , Feminino , Humanos , Terapia de Imunossupressão , Imageamento por Ressonância Magnética , Esclerose Múltipla/tratamento farmacológico , Plasmaferese , Gravidez , Complicações na Gravidez/tratamento farmacológico , Esteroides/uso terapêutico
6.
Eur J Neurol ; 14(12): 1344-50, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17941857

RESUMO

Huntington disease (HD) is a neurodegenerative disorder due to an excessive number of CAG repeats in the IT15 gene on chromosome 4. Studies of cognitive function in asymptomatic gene carriers have yielded contradictory results. This study compared cognitive performance in 44 subjects with the HD mutation (group of carriers) who had no clinical signs of HD and 39 at-risk individuals without HD mutation (group of non-carriers). Neuropsychological evaluation focused on global cognitive efficiency, psychomotor speed, attentional, executive and memory functions. Significant differences, with lower performances in the group of gene carriers, were detected for some measures of psychomotor speed, attention and executive functioning (all P < 0.01). More differences between groups were observed for memory measures, in particular on the California Verbal Memory Test. Complementing these observations, cognitive scores were correlated with age in the group of gene carriers, but not in the group of non-carriers. This suggests that the cognitive changes precede the appearance of the motor and psychiatric symptoms in HD and that tests proved to be sensitive to early HD deficiencies are better suited than global cognitive efficiency scales to observe them.


Assuntos
Transtornos Cognitivos/genética , Predisposição Genética para Doença/genética , Heterozigoto , Doença de Huntington/complicações , Doença de Huntington/genética , Adolescente , Adulto , Fatores Etários , Cromossomos Humanos Par 4/genética , Transtornos Cognitivos/diagnóstico , Transtornos Cognitivos/fisiopatologia , Análise Mutacional de DNA , Progressão da Doença , Diagnóstico Precoce , Feminino , Testes Genéticos , Humanos , Proteína Huntingtina , Doença de Huntington/psicologia , Masculino , Transtornos da Memória/diagnóstico , Transtornos da Memória/genética , Transtornos da Memória/fisiopatologia , Pessoa de Meia-Idade , Mutação/genética , Proteínas do Tecido Nervoso/genética , Testes Neuropsicológicos , Proteínas Nucleares/genética , Valor Preditivo dos Testes , Prognóstico , Desempenho Psicomotor/fisiologia , Sensibilidade e Especificidade
8.
Rev Neurol (Paris) ; 163(12): 1232-5, 2007 Dec.
Artigo em Francês | MEDLINE | ID: mdl-18355471

RESUMO

INTRODUCTION: Tumor necrosis factor- (TNF) blockers are efficient in the treatment of autoimmune disorders such as inflammatory bowel disease and rheumatoid arthritis, but can induce CNS adverse effects including retrobulbar optic neuritis or aggravation of multiple sclerosis. OBSERVATION: We report a case of progressive demyelinating polyneuropathy after initiation of Adalimumab (Humira). Corticosteroid and intravenous immunoglobulins were ineffective but the neuropathy improved within six months after adalimunab discontinuation. DISCUSSION: This case, and other reports recently published suggest that anti-TNF alpha drugs can induce demyelinating neuropathy. CONCLUSION: Clinicians should be on the lookout for signs evocating neuropathy in patients given anti TNF alpha.


Assuntos
Anti-Inflamatórios/efeitos adversos , Anticorpos Monoclonais/efeitos adversos , Polirradiculoneuropatia/induzido quimicamente , Fator de Necrose Tumoral alfa/efeitos adversos , Adalimumab , Corticosteroides/uso terapêutico , Idoso , Anti-Inflamatórios/uso terapêutico , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Humanizados , Artrite Reumatoide/complicações , Artrite Reumatoide/tratamento farmacológico , Estimulação Elétrica , Eletromiografia , Eletrofisiologia , Feminino , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Polirradiculoneuropatia/tratamento farmacológico , Polirradiculoneuropatia/patologia , Fator de Necrose Tumoral alfa/uso terapêutico
9.
Rev Neurol (Paris) ; 163(2): 222-30, 2007 Feb.
Artigo em Francês | MEDLINE | ID: mdl-17351541

RESUMO

INTRODUCTION: Executive dysfunction is regularly reported in patients with Alzheimer's disease. Nevertheless few studies have focused on planning ability in this neurodegenerative disease. OBJECTIVES: This study aimed to investigate the formulation and the execution of plans in Alzheimer's disease using an ecological planning subtask derived from the Behavioural Assessment of the Dysexecutive Syndrome test battery, the "Zoo Map Test". There are two trials. The first trial consists of a "high demand" version of the subtask in which the subjects must plan in advance the order in which they will visit designated locations in a zoo (formulation level). In the second, or "low demand" version, the subject is simply required to follow a concrete externally imposed strategy to reach the locations to visit (execution level). The test was given to 16 patients with Alzheimer's disease and 13 normal elderly subjects. RESULTS: The two way ANOVAs mainly showed more difficulties in patients with Alzheimer's disease than in healthy elderly in both conditions. The difference between formulation and execution was greater in patients with Alzheimer's disease than in healthy elderly. Planning impairments mainly correlated with behavioural changes (in particular motivational changes) observed by patient's relatives. CONCLUSION: These results suggest that patients with Alzheimer's disease have some problems to mentally develop logical strategies and to execute complex predetermined plans, which are partially related to behavioural changes.


Assuntos
Doença de Alzheimer/psicologia , Tomada de Decisões , Testes Neuropsicológicos , Idoso , Feminino , Humanos , Masculino , Mapas como Assunto , Motivação , Inquéritos e Questionários
10.
Rev Med Interne ; 28(9): 651-4, 2007 Sep.
Artigo em Francês | MEDLINE | ID: mdl-17532100

RESUMO

We report a case of polyarteritis nodosa revealed by intracranial haemorrhage. A 40-year-old woman presented two episodes of cerebral haemorrhage twelve days apart, the second due to an aneurysm rupture. The diagnosis of polyarteritis nodosa (PAN) was based on the following criteria: histological aneurysm examination, angiography suggesting PAN with cerebral, renal and splenic localizations, loss of weight and cutaneous nodules. Cerebral haemorrhage in PAN is rare and exceptionally the presenting feature of the disease.


Assuntos
Hemorragia Cerebral/etiologia , Poliarterite Nodosa/diagnóstico , Adulto , Angiografia Cerebral , Hemorragia Cerebral/diagnóstico por imagem , Feminino , Humanos , Distúrbios Menstruais/etiologia , Poliarterite Nodosa/diagnóstico por imagem
11.
Eur Psychiatry ; 21(3): 186-93, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16386408

RESUMO

Psychiatric disorders, especially depression, are frequent in patients with multiple sclerosis (MS). They are attributed both to the psychosocial impact of a chronic, usually progressive, disabling illness and to cerebral demyelination. Besides, drugs such as corticosteroids and possibly interferon (IFN) may also have depressogenic effects. Major depressive disorders and/or suicidal ideation are a major concern and efforts to identify and minimize these reactions are of much importance. Psychiatric side effects, particularly depression, are widely reported with IFN-alpha and have been suspected with IFN-beta but are not yet fully established. Our review of the literature revealed that most studies discard an association between IFN-beta and depression or suicide. However, few patients, especially those with a history of depression, might be at higher risk for depression when treated with IFN-beta. Overall, considering the uncertainty of a link between IFN-beta and depression and/or suicide, as well as the complete remission of psychiatric complications after IFN discontinuation and/or antidepressant treatment, physicians should closely monitor the psychiatric status of patients, but should not refrain from including them in IFN-beta treatment programs, even when they have past or present depression.


Assuntos
Adjuvantes Imunológicos/efeitos adversos , Transtorno Depressivo/psicologia , Interferon beta/efeitos adversos , Esclerose Múltipla/tratamento farmacológico , Esclerose Múltipla/psicologia , Transtorno Depressivo/induzido quimicamente , Transtorno Depressivo/etiologia , Humanos , Transtornos do Humor/induzido quimicamente , Transtornos do Humor/etiologia , Transtornos do Humor/psicologia , Esclerose Múltipla/complicações , Transtornos Psicóticos/etiologia , Transtornos Psicóticos/psicologia , Fatores de Risco , Suicídio/psicologia
12.
Rev Neurol (Paris) ; 162(10): 980-9, 2006 Oct.
Artigo em Francês | MEDLINE | ID: mdl-17028566

RESUMO

INTRODUCTION: Idiopathic Acute Transverse Myelitis (ATM) is an inflammatory and immune-mediated disorder, distinct from infectious ATM, ATM of systemic lupus erythematosus or Sjögren's syndrome, and medullary manifestation of multiple sclerosis. Prognosis is not well-known. OBJECTIVE: To evaluate clinical, paraclinical and pronognosis data in patients selected with new diagnosis criteria, classically described in idiopathic ATM. METHODS: Seventeen patients with diagnosis criteria were retrospectively (1996-2005) studied. A telephone investigation was conducted in 2005 to obtained data on the clinical course. RESULTS: Seven men and 10 women, ranging in age from 15 to 75 years (mean: 39.8 years) met these new criteria. Our study showed that epidemiological and clinical findings as well as laboratory results were in agreement with those presented in the literature. Conversely, prognosis was better since 76p.cent of the patients could walk without assistance. The clinical presentation of some of our patients and/or their progression towards other multifocal inflammatory disorders, suggests there might be links between ATM, neuromyelitis optica (NMO) and Acute Dissemined Encephalomyelitis (ADEM). CONCLUSION: Patients with idiopathic ATM, selected with new criteria, have a rather good prognosis. ATM seems to be part of a continuum of neuroimmunologic disorders including NMO or ADEM although reasons explaining distinct focal disorders remain unclear.


Assuntos
Mielite Transversa/diagnóstico , Adolescente , Adulto , Idoso , Criança , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mielite Transversa/fisiopatologia , Paraplegia/etiologia
13.
Biochim Biophys Acta ; 1317(2): 127-33, 1996 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-8950198

RESUMO

The molecular defects in the HEXB gene encoding the common beta-subunit of lysosomal beta-hexosaminidase A (beta-Hex A, alpha beta) and beta-Hex B (beta beta) were investigated in a Portuguese family affected with late onset Sandhoff disease (GM2-gangliosidosis variant 0). This family comprised two unaffected daughters and three affected sibs who developed at about age 17 cerebellar ataxia and mental deficiency. Their parents were consanguineous and clinically asymptomatic. There was no detectable beta-Hex B activity and a profound reduction in the activity of beta-Hex A in the leukocytes and transformed lymphoid cell lines from the affected sibs. The expected intermediate values were observed in the parents as well as in one daughter and her children. Western analysis revealed the presence of reduced, but detectable amounts of mature beta-chain protein in cell lysates from the probands and intermediate levels in the parents. Nucleotide sequencing of amplified, reverse-transcribed beta-chain mRNA demonstrated the presence of two single point mutations: an A619 to G transition in exon 5 (Ile207-->Val), and a G1514 to A transition in exon 13 (Arg505-->Gln). Both of these two mutations have been previously linked to the adult form of Sandhoff disease in compound heterozygote patients. All three affected sibs were found to be homoallelic for both mutations. Interestingly, while the mother was heterozygous for each mutation, the father was homozygote for the A619-->G substitution and heterozygote for the G1514-->A transition. Since the father is homozygote for the A619-->G mutation but expresses a biochemical phenotype consistent with a carrier of Sandhoff disease and is clinically asymptomatic, this substitution is likely a neutral mutation. We confirmed this hypothesis by finding this transition present in 4 of 30 alleles from normal individuals. We conclude that homozygosity for the G1514-->A mutation is exclusively responsible for the adult form of Sandhoff disease in this family, and that the A619-->G substitution is not a deleterious mutation but rather a common HEXB polymorphism.


Assuntos
Doença de Sandhoff/genética , beta-N-Acetil-Hexosaminidases/genética , Adulto , Feminino , Hexosaminidase B , Homozigoto , Humanos , Masculino , Linhagem , Fenótipo , Mutação Puntual , Polimorfismo de Fragmento de Restrição , Doença de Sandhoff/enzimologia
14.
Rev Neurol (Paris) ; 161(1): 55-60, 2005 Jan.
Artigo em Francês | MEDLINE | ID: mdl-15678001

RESUMO

INTRODUCTION: The consequences of axonal or demyelinating injuries on the axonal cytoskeleton have rarely been described. METHODS: We have compared the density of fibers labeled by anti-neurofilaments (NF) and -beta tubulin (TUB) to the density of total fibers in nine patients with axonal neuropathies of undetermined etiology (AUE), six with necrotizing angeitis with neuropathy (NAN), seven with chronic inflammatory demyelinating neuropathy (CIDP) and in five controls, as well as in six patients with chronic multiple sclerosis (MS). We also studied demyelinated rat corpus callosum after lysophosphatidyl (LPC) microinjection. RESULTS: In AUE and NAN NF positive fibers decreased together with total fiber density, whereas TUB increased. In demyelinating lesions TUB was not altered (CIDP) or strongly decreased (MS, LPC); NF were strongly reduced in MS (where axon loss was prominent) and in LPC lesions (despite the lack of fiber degeneration) and for fiber densities<3900/mm2 in CIDP. CONCLUSION: The initial mechanism of a disease, either axonal degeneration or demyelination, could result into a specific pattern of axonal cytoskeleton alterations.


Assuntos
Doenças Desmielinizantes/patologia , Lesão Axonal Difusa/patologia , Microtúbulos/patologia , Fibras Nervosas/patologia , Idoso , Animais , Axônios/patologia , Contagem de Células , Corpo Caloso/patologia , Doenças dos Nervos Cranianos/patologia , Doenças Desmielinizantes/induzido quimicamente , Feminino , Humanos , Imuno-Histoquímica , Lisofosfatidilcolinas , Masculino , Microinjeções , Pessoa de Meia-Idade , Esclerose Múltipla/patologia , Proteínas de Neurofilamentos/metabolismo , Placa Amiloide/patologia , Poliarterite Nodosa/patologia , Polirradiculoneuropatia/patologia , Ratos , Técnicas Estereotáxicas , Tubulina (Proteína)/metabolismo
15.
Rev Neurol (Paris) ; 161(4): 451-4, 2005 Apr.
Artigo em Francês | MEDLINE | ID: mdl-15924081

RESUMO

INTRODUCTION: In 1961, Garcin et al. described a family with several members affected with optic atrophy associated with cataract, and neurological symptoms. The authors believed this condition to be distinct from other diseases known at that time, e.g. the Behr syndrome, Marinesco-Sjogren syndrome and Friedreich's ataxia. METHOD: This family was followed over a period of 40 years and genes known to be responsible for optic atrophy were sequenced. RESULTS: The G277A mutation of OPA3 gene was responsible for this familial disease. DISCUSSION: A new clinical entity is identified: autosomal dominant optic atrophy and cataract, due to a heterozygous mutation of the OPA3 gene, a nuclear gene encoding a mitochondrial protein.


Assuntos
Doenças dos Gânglios da Base/genética , Catarata/genética , Mutação , Atrofias Ópticas Hereditárias/genética , Proteínas/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças dos Gânglios da Base/complicações , Catarata/complicações , Criança , Feminino , Seguimentos , Humanos , Pessoa de Meia-Idade , Atrofias Ópticas Hereditárias/complicações , Linhagem
16.
Ann Readapt Med Phys ; 48(9): 662-7, 2005 Dec.
Artigo em Francês | MEDLINE | ID: mdl-16023757

RESUMO

UNLABELLED: Modifications of the medical curriculum have included a compulsory course on disability. OBJECTIVE: To determine whether attendance in a course on disability and/or rotations in physical medicine and rehabilitation departments modify the attitude of medical students towards disabled people. METHODS: All third- and fourth-year students completed a translated version of the ATDPb. This questionnaire rates items evaluating attitude towards disabled people on a 6-point scale (minimum 0; maximum 180). Retro-translation was performed to control the translation. During the second year, all students had attended a general course in ethics. Fourth-year students had attended a 17 hours course on disability, and 21 of 78 had spent 9 weeks in the physical medicine and rehabilitation department. The study compares fourth-year students to third-year students, considered as controls, and students having spent a rotation in the physical medicine and rehabilitation department to others. RESULTS: The mean score of all students was 108.86+/-15.84 (73-160) on the ATDP scale. Males and females did not differ significantly, and the score did not change from that before the course on disability (109.95+/-14.98 vs 107.6+/-16.65, P=0.23) nor after a rotation in the physical medicine and rehabilitation department (113.52+/-11.42 vs 108.54+/-16.03, P=0.14). CONCLUSION: Development and validation of scores that would fit better to the European cultural context would be useful. The present method of theoretical courses and rotations do not improve the attitude of students towards disabled people and should be modified if this objective is to be achieved.


Assuntos
Atitude Frente a Saúde , Pessoas com Deficiência , Educação de Graduação em Medicina , Estudantes de Medicina/psicologia , Inquéritos e Questionários , Educação de Graduação em Medicina/métodos , Feminino , Departamentos Hospitalares , Humanos , Masculino , Reabilitação
17.
J Neuropathol Exp Neurol ; 62(12): 1211-9, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14692697

RESUMO

A major cytopathological hallmark of amyotrophic lateral sclerosis (ALS) is the presence of axonal spheroids containing abnormally accumulated neurofilaments. The mechanism of their formation, their contribution to the disease, and the possibility of other co-aggregated components are still enigmatic. Here we analyze the composition of such lesions with special reference to stable tubule only polypeptide (STOP), a protein responsible for microtubule cold stabilization. In normal human brain and spinal cord, the distribution of STOP proteins is uniform between the cytoplasm and neurites of neurons. However, all the neurofilament-rich spheroids present in the tissues of affected patients are intensely labeled with 3 different anti-STOP antibodies. Moreover, when neurofilaments and microtubules are isolated from spinal cord and brain, STOP proteins are systematically co-purified with neurofilaments. By SDS-PAGE analysis, no alteration of the migration profile of STOP proteins is observed in pathological samples. Other microtubular proteins, like tubulin or kinesin, are inconstantly present in spheroids, suggesting that a microtubule destabilizing process may be involved in the pathogenesis of ALS. These results indicate that the selective co-aggregation of neurofilament and STOP proteins represent a new cytopathological marker for spheroids.


Assuntos
Esclerose Lateral Amiotrófica/metabolismo , Proteínas Associadas aos Microtúbulos/análise , Microtúbulos/metabolismo , Proteínas de Neurofilamentos/metabolismo , Esferoides Celulares/metabolismo , Esferoides Celulares/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Esclerose Lateral Amiotrófica/patologia , Animais , Encéfalo/patologia , Agregação Celular/fisiologia , Feminino , Humanos , Masculino , Camundongos , Pessoa de Meia-Idade
18.
Eur J Hum Genet ; 7(3): 404-6, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10234520

RESUMO

Optic neuritis frequently occurs in multiple sclerosis (MS), and shares several similarities with the optic neuritis of Leber's hereditary optic neuropathy (LHON), which is mainly due to maternally transmitted mitochondrial DNA (mtDNA) mutations. Our report shows for the first time that a mitochondrial DNA background could influence the clinical expression of MS. One European mtDNA haplogroup was found only in MS patients with optic neuritis but not in MS patients without visual symptoms. Therefore, we hypothesize that mtDNA haplogroup J might constitute a risk factor for optic neuritis occurrence when it is coincidentally associated with MS, but not be a risk factor for developing MS per se as suggested previously.


Assuntos
DNA Mitocondrial , Esclerose Múltipla/genética , Neurite Óptica/genética , Alelos , Feminino , Humanos , Masculino , Esclerose Múltipla/fisiopatologia , Fenótipo
19.
Neuromuscul Disord ; 8(7): 459-66, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9829275

RESUMO

A distal myopathy characterised by an autosomal dominant inheritance, with clinical onset around the age of 60, early involvement of posterior leg and thigh muscles, and normal or slightly-elevated creatine kinase levels was identified in three members of a French kindred. Tibialis anterior muscles were involved only in the most severely-affected sibling. Histological features included large multiple nonrimmed vacuolation and focal intrasarcoplasmic masses which immunoreacted with the anti-desmin antibody. Cytoplasmic and intranuclear tubulofilamentous inclusions were observed by electron microscopy. The condition of this familial syndrome is discussed in relation to previously-identified autosomal dominant distal myopathies and inclusion body myopathies.


Assuntos
Genes Dominantes/genética , Doenças Musculares/genética , Idade de Início , Feminino , Humanos , Perna (Membro) , Masculino , Microscopia Eletrônica , Pessoa de Meia-Idade , Músculos/patologia , Músculos/ultraestrutura , Doenças Musculares/patologia , Linhagem
20.
Autoimmunity ; 26(3): 189-94, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9550286

RESUMO

It has been suggested that inflammation may be a possible cause of Alzheimer's disease (AD). Increased anti-NGF autoantibody levels and increased NGF frequency in serum have previously been associated with inflammatory responses. In this study no changes in anti-NGF autoantibody titers or in NGF frequency were detected in sera of AD patients, suggesting that they are not involved in the neuroimmunological mechanisms underlying AD. There were neither age-associated changes in NGF frequency in sera of four groups of normal subjects between 18-91 years of age. In contrast, anti-NGF autoantibodies were significantly increased in sera of the 31-45 yr age group.


Assuntos
Doença de Alzheimer/imunologia , Autoanticorpos/sangue , Fatores de Crescimento Neural/sangue , Fatores de Crescimento Neural/imunologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Envelhecimento , Doença de Alzheimer/sangue , Autoanticorpos/líquido cefalorraquidiano , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA